Agenus AGEN
NASDAQ AGEN
$8.24 +0.00 (+0.00%)
As of: Sep 4, 2026 · 3:59 PM EDT

Agenus (AGEN) Net Equity Issued and Repurchased (2010 - 2026)

Agenus (AGEN) posted quarterly Net Equity Issued and Repurchased of $996000.0 for Q1 2026, down 84.3% year-over-year from $6.3 million in Q1 2025, and down 88.43% quarter-over-quarter from $8.6 million in Q4 2025.

Analysis

Agenus (AGEN) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends

Agenus' Net Equity Issued and Repurchased history runs 16 years deep, the most recent figure standing at $996000.0 for Q1 2026.

  • In Q1 2026, Net Equity Issued and Repurchased fell 84.3% year-over-year to $996000.0; the TTM figure through Mar 2026 stood at $30.8 million (up 38.72% YoY), while the FY2025 annual figure was $36.1 million, up 9.43% from the prior year.
  • Net Equity Issued and Repurchased for Q1 2026 stood at $996000.0, down from $8.6 million in the prior quarter.
  • The five-year high for Net Equity Issued and Repurchased was $60.6 million in Q1 2023, with the low at $996000.0 in Q1 2026.
  • The 5-year median for Net Equity Issued and Repurchased is $12.2 million (2025), against an average of $17.8 million.
  • The sharpest annual moves came in 2024 and 2025: Net Equity Issued and Repurchased sank 95.29% in 2024, then surged 513.92% in 2025.
  • Agenus' Net Equity Issued and Repurchased stood at $24.0 million in 2022, then tumbled by 58.36% to $10.0 million in 2023, then declined by 28.98% to $7.1 million in 2024, then rose by 21.52% to $8.6 million in 2025, then sank by 88.43% to $996000.0 in 2026.
  • Business Quant data shows AGEN's Net Equity Issued and Repurchased at $996000.0 in Q1 2026, $8.6 million in Q4 2025, and $9.0 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 141.90 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Agenus 342.07 Mn 342.07 Mn 34.52 Mn 14.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.10 Mn
Mar 31, 2026 996,000.00
Dec 31, 2025 8.61 Mn
Sep 30, 2025 8.97 Mn
Jun 30, 2025 12.22 Mn
Mar 31, 2025 6.34 Mn
Dec 31, 2024 7.09 Mn
Sep 30, 2024 6.78 Mn
Jun 30, 2024 1.99 Mn
Mar 31, 2024 17.17 Mn
Dec 31, 2023 9.98 Mn
Sep 30, 2023 20.35 Mn
Jun 30, 2023 42.25 Mn
Mar 31, 2023 60.58 Mn
Dec 31, 2022 23.96 Mn
Sep 30, 2022 27.83 Mn
Jun 30, 2022 28.24 Mn
Mar 31, 2022 19.18 Mn
Dec 31, 2021 50.21 Mn
Sep 30, 2021 77.43 Mn